SEC Form 4 · accession 0001179110-15-013550
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michelle Dipp
Officer — Chief Executive Officer · Director
Period of report
Sep 30, 2015
Accepted (ET)
Oct 2, 2015 · 8:26 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 30, 2015 | F | 1,256 | $8.49 | D | 985,501 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the Registrant to satisfy minimum statutory withholding requirements upon vesting of time-based RSUs.
- F2Represents 966,186 shares of common stock and 19,315 RSUs.